Currently, the top ten CROs represent more than half the market, and as the industry continues to grow analysts suggest companies expand revenue streams through “nontraditional” services offerings.
Metrion Biosciences (Metrion), an ion-channel and drug discovery CRO, has joined a network of partners to evaluate the use of primary human dorsal root ganglion (hDRG) neurons in pain research.
AMRI and the University at Albany’s RNA Institute are partnering to speed the development of new RNA-based therapeutics in an “ideal and first of its kind” collaboration.
The US FDA has warned API manufacturer Unimark Remedies about unsanitary conditions at its facility in Vapi and Bavla in India.
Marken’s Moscow-based depot has been granted a new pharmaceutical license from the Russian Federation, further extending the company’s capabilities in the area.
Biomedical Systems and Foundry Health of Chicago will collaborate to develop the proprietary cloud-based data management system, which will cover all study phases.